-
effectivehealthcare-admin.ahrq.gov/products/stroke-atrial-fibrillation/research
December 01, 2019 - antithrombotic strategies, devices, and oral anticoagulants, including oral direct thrombin inhibitors and factor … We found that a factor IIa inhibitor (dabigatran 150 mg) was superior to warfarin in reducing the incidence
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/breast-biopsy-executive.pdf
December 01, 2009 - intended to evaluate the accuracy of different methods
of performing breast biopsy and to explore what
factor … factors on accuracy and harms
Strength of
evidence
Impact on Impact on supporting the
Category Factor … improves Insufficient data Insufficient
experience with experience
Insufficient data for any other factor … category Factor Level of evidence factor on accuracy
Patient characteristics Patient age Insufficient … on
Factor category Factor Level of evidence harms
Patient characteristics Patient age Insufficient
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/thromboembolism-update_research-protocol.pdf
February 17, 2016 - There were few studies
evaluating the new factor Xa inhibitors. … or treatment
durations of the same thromboprophylaxis interventions (low molecular weight heparin,
factor … All KQ
o Injectable unfractionated heparin KQ 1, 4 (in combination), 5, 6
o Injectable or oral factor … for postthrombotic
syndrome and proximal DVTs are believed to be a higher risk factor … 1) comparisons of classes of thromboprophylaxis interventions (e.g., low
molecular weight heparin, factor
-
effectivehealthcare-admin.ahrq.gov/health-topics/autoimmune-diseases?page=0
November 01, 2024 - Report
Systematic Review Archived March 7, 2012
Antinuclear Antibody, Rheumatoid Factor … Research Protocol Archived September 29, 2010
Antinuclear Antibody, Rheumatoid Factor
-
effectivehealthcare-admin.ahrq.gov/health-topics/autoimmune-diseases
November 01, 2024 - Report
Systematic Review Archived March 7, 2012
Antinuclear Antibody, Rheumatoid Factor … Research Protocol Archived September 29, 2010
Antinuclear Antibody, Rheumatoid Factor
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/prostate-cancer-surveillance_executive.pdf
December 01, 2011 - Behavioral indications
No cohort used this factor. … Gleason score
No cohort used this factor. … Behavioral indications
No cohort explicitly used this factor. … Availability of technology
No study addressed this factor. … Small area variation
No study addressed this factor.
-
effectivehealthcare-admin.ahrq.gov/health-topics/arthritis?page=0
November 14, 2023 - Update
Systematic Review Archived March 7, 2012
Antinuclear Antibody, Rheumatoid Factor … Research Protocol Archived September 29, 2010
Antinuclear Antibody, Rheumatoid Factor
-
effectivehealthcare-admin.ahrq.gov/health-topics/arthritis
November 14, 2023 - Update
Systematic Review Archived March 7, 2012
Antinuclear Antibody, Rheumatoid Factor … Research Protocol Archived September 29, 2010
Antinuclear Antibody, Rheumatoid Factor
-
effectivehealthcare-admin.ahrq.gov/health-topics/connective-tissue-disorders
May 24, 2017 - Report
Systematic Review Archived March 7, 2012
Antinuclear Antibody, Rheumatoid Factor … Research Protocol Archived September 29, 2010
Antinuclear Antibody, Rheumatoid Factor
-
effectivehealthcare-admin.ahrq.gov/products/autoimmune-disease/rapid-research
October 01, 2024 - There is weak evidence for lowering of other inflammatory markers like Tumor necrosis factor alpha (TNFα … weak evidence for other outcomes like anti-citrullinated protein autoantibodies (ACPAs), rheumatoid factor
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/dcis-prognostic-tests_research.pdf
August 22, 2012 - Data Points 15: Breast Cancer Diagnostic Workup: Prognostic factor testing among older women with ductal … situ and early invasive breast cancer
Breast Cancer Diagnostic Workup Data Points # 15
Prognostic factor … Current guidelines do not recommend
routine testing for human epidermal growth
factor receptor 2 (HER2 … Prognostic factor testing among older
women with ductal carcinoma in situ and early
invasive breast … ER = estrogen receptor, PR = progesterone receptor, HER2 = human epidermal growth factor receptor-2.
-
effectivehealthcare-admin.ahrq.gov/health-topics/health-facilities?page=4
July 12, 2011 - October 29, 2010
Utilization and Clinical Data on In-Hospital Off-Label Uses of Recombinant Factor … Review Archived June 1, 2010
Comparative Effectiveness of In-Hospital Use of Recombinant Factor
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/musculoskeletal-complaints-tests-children_executive.pdf
March 01, 2012 - 1
Comparative Effectiveness Review
Number 50
Antinuclear Antibody, Rheumatoid Factor, and
Cyclic-Citrullinated … Frequency of antinuclear
antibodies and rheumatoid factor in healthy Turkish children. … Rheumatoid factor in children
with lupus erythematosus. A serologic study. … Utility of
rheumatoid factor in the diagnosis of juvenile rheumatoid arthritis. … factor in juvenile chronic
arthritis.
-
effectivehealthcare-admin.ahrq.gov/products/antidepressants-seniors-pneumonia/research
January 01, 2020 - One major etiologic factor for pneumonia in the elderly is aspiration of oropharyngeal contents [ 3 , … We then examined each potential confounding factor individually using a change-in-estimate criterion … In particular, we individually added each potential confounding factor to the minimally adjusted model … If any factor changed the OR of interest by ten percent or more, we considered it to be a confounding … factor and retained it in the "change-in-estimate" adjusted model.
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/ehc-presentation-quantitative-synthesis-chapter-3.pdf
February 01, 2018 - For example, recommend against selecting fixed effects model because
P>0.1
► Such approaches do not factor … large effect sizes, or more frequent
outcomes (5-10%), the Mantel-Haenszel method (without correction factor … consider the Peto method, the Mantel-Haenszel method, or logistic regression
without correction factor … method, the Mantel-
Haenszel method, or a logistic regression approach, without adding a
correction factor
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/juvenile-arthritis-dmards_overview.pdf
March 27, 2014 - g Categories of JIA include:
• Systemic arthritis
• Oligoarthritis
• Rheumatoid-factor positive ( … RF+) polyarthritis
• Rheumatoid-factor negative (RF-) polyarthritis
• Enthesitis-related arthritis
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/juvenile-arthritis-dmards_executive.pdf
September 01, 2011 - Comparative Effectiveness Review
Number 28
Effective
Health Care
2
• Rheumatoid-factor positive … • Rheumatoid-factor negative (RF-) polyarthritis:
Affects five or more joints during the first 6
months … (FDA) recently
placed a box warning on the entire class of biologic
DMARDs targeting tumor necrosis factor … (g) Categories of JIA include:
• Systemic arthritis
• Oligoarthritis
• Rheumatoid-factor positive … (RF+)
Polyarthritis
• Rheumatoid-factor negative (RF-)
polyarthritis
• Enthesitis-related arthritis
-
effectivehealthcare-admin.ahrq.gov/health-topics/dietary-proteins?page=3
August 29, 2011 - October 29, 2010
Utilization and Clinical Data on In-Hospital Off-Label Uses of Recombinant Factor … Review Archived June 1, 2010
Comparative Effectiveness of In-Hospital Use of Recombinant Factor
-
effectivehealthcare-admin.ahrq.gov/health-topics/throat-cancer
For example, having HPV is a risk factor for oropharyngeal cancer.
-
effectivehealthcare-admin.ahrq.gov/products/rheumatoid-arthritis-medicine-update/final-report-update-2018
October 01, 2019 - Two-agent treatments with MTX and tumor necrosis factor (TNF) biologics or non-TNF biologics most likely … Combination therapy with TNF (tumor necrosis factor) or non-TNF biologics plus MTX improved disease control